Revvity, Inc. (RVTY)
NYSE·Healthcare·Medical - Diagnostics & Research
$85.48
-1.52%
Mkt Cap $10.54B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 2, 2026 | $764.94M | $772.06M | +0.93% | $1.57 | $1.70 | +8.28% | — | — |
| Q4 2025 Oct 27, 2025 | $699.36M | $698.95M | -0.06% | $1.14 | $1.18 | +3.51% | — | — |
| Q3 2025 Jul 28, 2025 | $699.89M | $720.28M | +2.91% | $1.14 | $1.18 | +3.51% | — | — |
| Q2 2025 Apr 28, 2025 | $710.82M | $664.76M | -6.48% | $0.96 | $1.01 | +5.21% | — | — |
| Q1 2025 Jan 31, 2025 | $665.29M | $729.37M | +9.63% | $1.37 | $1.42 | +3.65% | — | — |
| Q4 2024 Nov 4, 2024 | $679.66M | $684.05M | +0.65% | $1.13 | $1.28 | +13.27% | — | — |
| Q3 2024 Jul 29, 2024 | $690.33M | $691.68M | +0.20% | $1.12 | $1.22 | +8.93% | — | — |
| Q2 2024 Apr 29, 2024 | $647.25M | $649.92M | +0.41% | $0.94 | $0.98 | +3.92% | — | — |
| Q1 2024 Feb 1, 2024 | $677.94M | $695.90M | +2.65% | $1.15 | $1.25 | +8.70% | — | — |
| Q4 2023 Oct 30, 2023 | $695.33M | $670.74M | -3.54% | $1.19 | $1.18 | -0.84% | — | — |
| Q3 2023 Aug 1, 2023 | $696.13M | $709.07M | +1.86% | $1.18 | $1.21 | +2.54% | — | — |
| Q2 2023 May 11, 2023 | $678.90M | $674.87M | -0.59% | $1.06 | $1.01 | -4.72% | — | — |
| Q1 2023 Feb 14, 2023 | $1.03B | $741.21M | -27.96% | $1.66 | $1.70 | +2.41% | — | — |
| Q4 2022 Oct 2, 2022 | $1.02B | $711.80M | -30.30% | $1.44 | $0.55 | -61.87% | — | — |
| Q3 2022 Jul 3, 2022 | $1.20B | $1.23B | +2.15% | $2.01 | $1.42 | -29.35% | — | — |
| Q1 2022 Mar 31, 2022 | $1.19B | $1.26B | +5.92% | $2.12 | $1.40 | -33.96% | — | — |
| Q4 2021 Dec 31, 2021 | — | $1.36B | — | — | $1.50 | — | — | — |
| Q3 2021 Sep 30, 2021 | $1.27B | $1.17B | -8.39% | $2.25 | $1.11 | -50.67% | — | — |
| Q2 2021 Jun 30, 2021 | — | $1.23B | — | — | $2.19 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $1.31B | — | — | $3.37 | — | — | — |